From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages) View the PDF document
Table of Contents
View the documentAcknowledgments
View the documentAcronyms and abbreviations
View the documentForeword
Open this folder and view contents1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
Open this folder and view contents2. Overview of antiretroviral therapy, adherence and drug-resistance
Open this folder and view contents3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
View the document4. There's hope - early observations of ARV treatment roll-out in South Africa
Close this folderFactors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
View the documentAcknowledgements
View the documentAcronyms and abbreviations
View the documentExecutive summary
Open this folder and view contentsChapter 1: Introduction
Open this folder and view contentsChapter 2: Background
Close this folderChapter 3: Methodology
View the document3.1 Introduction
View the document3.2 Study design
View the document3.3 Study population
View the document3.4 Description of study sites
View the document3.5 Inclusion and exclusion criteria
View the document3.6 Selection and training of data collectors
View the document3.7 Qualitative data collection
View the document3.8 Observations
View the document3.9 Semi-structured interviews
View the document3.10 Exit interviews
View the document3.11 Focus group discussions
View the document3.12 Quantitative data
View the document3.13 Data analysis
View the document3.14 Emic perspective
View the document3.15 Ethical considerations
View the document3.16 Feedback
Open this folder and view contentsChapter 4: Quantitative results
Open this folder and view contentsChapter 5: Qualitative results
Open this folder and view contentsChapter 6: Discussion, conclusion and recommendations
View the documentReferences
View the documentAnnex 1: Mean of rates adherence
View the documentAnnex 2: Multivariate logistic regression analyses on the predictor variables
View the documentAnnex 3: Questionnaires
Open this folder and view contentsA study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
Open this folder and view contentsFactors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
View the documentBack cover
 

3.13 Data analysis

Quantitative data

Quantitative data were initially stored in an Access database (Microsoft Access, 2003). Statistics were generated using Epi Info and SPSS version 13.0. The crude prevalence of adherence was estimated and its 95% confidence interval calculated. The Chi-square test was used to compare adherence rates among two or more categories. Logistic regression models were used to determine predictors of adherence and to estimate the independent and multiple effects of selected factors on adherence. All hypotheses were tested using α = 0.05 level of significance.

Adherence rates, measured as the percentage of pill intake over a specified time, were estimated using three methods: two-day recall using a 'sun and moon chart', which depicted the sun at different times of the day and the moon at night; visual analogue (a one-month recall using an uncalibrated 10 cm line); and a one-month pharmacy pill count. In the visual analogue, respondents were requested to indicate, by marking on the line, how they perceived their adherence over the past month. The overall adherence rate was estimated as a composite measure (i.e. the average of the one-month visual analogue, pharmacy pill count (one-month) and the two-day recall.

Pill count (one-month)

Pill counts were calculated by subtracting the number of pills returned from the number of pills issued. This provided the amount of medication used by the patient during this period. The amount used is then divided by the expected amount and multiplied by 100 to determine the percentage adherence per participant.

Self-report (two-day recall)

In the two-day recall the patients were asked to recall the frequency and timing of medication as well as their food intake over the previous two days. The data were captured in the sun and moon chart.

Self-report (one-month recall)

Participants were asked to indicate their adherence rate using a visual analogue line measuring 10 cm. The distance from zero to the tick on the line multiplied by 10 was considered to be the estimated percentage adherence rate.

Most of the patients interviewed were on first-line regimens, which include: efavirenz, lamivudine and zidovudine. These do not have any food requirements. However, some patients may choose to take them after meals to reduce nausea. Therefore since most of the ARV combinations used for first-line regimen in Botswana do not necessarily require that they be taken with food, the variable timing of taking medication and whether the drugs were taken with food or not were dropped in the analysis.

Qualitative data

The qualitative data collected were analysed with a view to gaining understanding of the factors that influenced adherence to ART. The data analysis process included a four-day workshop, with technical assistance provided by the University of Amsterdam. The work involved reading through the data from the qualitative research tools - which included the semi-structured interviews with health workers and ARV users, and the FGDs with ARV users and the community - in order to identify key themes. Initially, 28 themes were identified. The quotes were then manually pasted onto theme cards for easy perusal. A general thematic analysis was then conducted, focusing on similarities and differences of perspective between different groups of respondents. Further analysis revealed that the themes appeared to be linked, and these were then analysed together. Information was analysed to capture the different perspectives of the different actors: ARV users, health workers and community members. Where there were agreements or conflicting views, these were shown.

to previous section to next section
 

Last updated: May 3, 2013